Epicypher, INC.
Doing business as Epicypher INC
At a glance
Employees20-99
In business since2012
HeadquartersDurham, NC
US patents4
SAM.gov UEIUWNWSADJYYZ3
CAGE code6XLY4
Incorporated inDE
- reagents
- DNA methylation sequencing
- CUT&RUN
- genomic mapping
- nucleosomes
- components
- bioinformatic analysis
- antibodies
- chromatin remodeling assays
Named on the company’s own website, read JUL 29, 2026
What they make
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
4 US patents granted 2020–2024, 3 of them in the five years to SEP 2025.
Measurement 3Biotechnology 1
- Quantification of nucleosome modifications using chemically-defined recombinant nucleosomesUS 12,104,199 · granted OCT 1, 2024
- Peptide ligase-mediated engineering of recombinant nucleosomesUS 11,739,128 · granted AUG 29, 2023
- Assays for nucleosome remodeling activityUS 11,493,520 · granted NOV 8, 2022
- Quantification of nucleosome modifications using chemically-defined recombinant nucleosomesUS 10,787,697 · granted SEP 29, 2020
Granted to EpiCypher, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Epicypher, INC. | Durham | NC | 20–99 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.